Effect of health management service for hypertension patients under framework of Basic Public Health Service Project: a regression discontinuity design.
10.3760/cma.j.cn112338-20220721-00649
- VernacularTitle:基本公共卫生服务项目框架下高血压患者管理服务的效果评价：基于断点回归设计
- Author:
Si Xuan LI
1
;
Wei JI
2
;
Xin Yu WEI
3
;
Jun CUI
1
;
Yan Yan YING
1
;
Jie Ping CHEN
1
;
Hui LI
4
;
Shi Wei LIU
5
Author Information
1. Department of Chronic and Non-communicable Disease Control and Prevention, Ningbo Municipal Center for Disease Control and Prevention, Ningbo 315010, China.
2. Department of Big Data, Ningbo Municipal Center for Disease Control and Prevention, Ningbo 315010, China.
3. Harris School of Public Policy, The University of Chicago, Chicago, Illinois 60637, USA.
4. Department of Health Promotion, Ningbo Municipal Center for Disease Control and Prevention, Ningbo 315010, China.
5. Tobacco Control Office, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Blood Pressure;
Health Services;
Hypertension;
Linear Models;
Physical Examination
- From:
Chinese Journal of Epidemiology
2023;44(5):772-777
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the effect of health management service on hypertension patients (HMSFHP) under the framework of the Basic Public Health Service Project by using regression discontinuity design. Methods: The participants were enrolled from an observational cohort survey in 2015 and followed up was conducted in 2019. The participants with SBP 130-150 mmHg and/or DBP 80-100 mmHg in the baseline survey of the cohort in 2015 were included in the present study. Additionally, we obtained the dates of participants receiving HMSFHP and their blood pressure data from follow-up records, physical examination records and telephone interview. The participants were divided into intervention group and control group based on the cutoff points, i.e. SBP ≥140 mmHg and/or DBP ≥90 mmHg. The local linear regression model were used to estimate the effect of HMSFHP on reducing blood pressure of the participants. Results: After adjusting for age, sex and time length of receiving HMSFHP, the results of the model including participants with 80-100 mmHg for DBP in 2015 indicated that, for the participants who received HMSFHP, the DBP decreased by 6.66 mmHg from 2015 to 2019. For the participants with SBP 130-150 mmHg in 2015, the reduction estimate of the model was -6.17 mmHg, the difference was not significant (P=0.178), suggesting that receiving HMSFHP did not cause change in SBP for the participants who received HMSFHP. Conclusion: Receiving HMSFHP had effect to reduce DBP, and HMSFHP had a positive effect on the control of blood pressure in patients with hypertension.
